Sai Parenterals Ltd vs Sunrest Lifescience Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Sai Parenterals Ltd is ₹ 490.05 as of 04 May 09:09 . The P/E Ratio of Sai Parenterals Ltd is 0 as of March 2023 .The P/E Ratio of Sunrest Lifescience Ltd is 0 as of March 2023 . The Market Cap of Sai Parenterals Ltd is ₹ 0 crore as of March 2023 .The Market Cap of Sunrest Lifescience Ltd is ₹ 0 crore as of March 2023 . The Dividend Payout of Sai Parenterals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sunrest Lifescience Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Sai Parenterals Ltd

Sai Parenteral's Limited was originally incorporated as Sai Parenteral's Private Limited', a Private Limited Company on January 12, 2001, with the Registrar of Companies, at Hyderabad.
Thereafter, Company was converted into a Public Limited Company and the name of Company was changed to Sai Parenteral's Limited' w.e.f January 17, 2022. Sai Parenteral's is a diversified pharmaceutical formulations company engaged in the business of Branded Generic Formulations and Contract Development and Manufacturing Organization (CDMO) products and services for the domestic and international markets.
Company has developed a comprehensive and diversified portfolio of complex pharmaceutical products, covering both high-value and high-volume categories addressing critical therapeutic needs across the multiple disease areas.

About Sunrest Lifescience Ltd

Sunrest Lifescience Limited was originally incorporated as 'Sunrest Lifescience Private Limited' as a Private Company vide Certificate of Incorporation dated October 30, 2017, with the Registrar of Companies, Gujarat.
Subsequently, Company was converted into a Public Limited Company and the name of Company was changed to 'Sunrest Lifescience Limited' on March 21, 2023. The Company is engaged in marketing of OTC generic pharmaceutical products into domestic market.
The Company operate in different States of India such as Maharashtra, Gujarat, Madhya Pradesh, Orissa and Rajasthan.
It deal in Capsules, Tablets, Syrup, Ointment, Gel, Mouth Wash, Solution, Suspension, Dry Powders and Toothpaste.
Their product portfolio comprises of drugs like Anti-Bacterial, Anti Diarrheal, AntiFungal, Dental Cure, Anti Malerial, Anti Diabetic, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical and Anti-inflammatory.

FAQs for the comparison of Sai Parenterals Ltd and Sunrest Lifescience Ltd

Which company has a larger market capitalization, Sai Parenterals Ltd or Sunrest Lifescience Ltd?

Market cap of Sai Parenterals Ltd is 2,148 Cr while Market cap of Sunrest Lifescience Ltd is 30 Cr

What are the key factors driving the stock performance of Sai Parenterals Ltd and Sunrest Lifescience Ltd?

The stock performance of Sai Parenterals Ltd and Sunrest Lifescience Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sai Parenterals Ltd and Sunrest Lifescience Ltd?

As of May 4, 2026, the Sai Parenterals Ltd stock price is INR ₹486.4. On the other hand, Sunrest Lifescience Ltd stock price is INR ₹36.1.

How do dividend payouts of Sai Parenterals Ltd and Sunrest Lifescience Ltd compare?

To compare the dividend payouts of Sai Parenterals Ltd and Sunrest Lifescience Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.